跳至主要内容
临床试验/ACTRN12621000531819
ACTRN12621000531819已完成未知

Effectiveness of a cluster-randomized trial of a community-based lifestyle intervention on hypoglycaeted haemoglobin (HbA1c) levels in people with type 2 diabetes in Kavrepalanchowk and Nuwakot districts of Nepal.

AMED0 个研究点目标入组 481 人开始时间: 2021年5月6日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
AMED
入组人数
481

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Open (masking not used)

入排标准

年龄范围
30 Years 至 60 Years(—)
性别
All

入选标准

  • Adults, the age group from 30 to 60 years who are clinically diagnosed with T2DM with their baseline HbA1c is greater than 6.5% will be included based on the American Diabetes Association (ADA) and WHO criteria for diagnosis and classification of diabetes.

排除标准

  • Clinically diagnosed with type 1 diabetes mellitus, Currently pregnant, and Critically ill patients who have no ability to participate in the program.

研究者

发起方
AMED

相似试验